BiOptic Inc. (6850.TWO)
TWD 43.4
(-9.58%)
TWD 43.4
(-9.58%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 12.59 Million TWD | 106.53% |
| 2022 | -192.87 Million TWD | -33.78% |
| 2021 | -144.17 Million TWD | -712.2% |
| 2020 | 23.55 Million TWD | 171.47% |
| 2019 | -32.95 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 13.76 Million TWD | 9.3% |
| 2023 FY | 12.59 Million TWD | 106.53% |
| 2023 Q4 | 12.59 Million TWD | 121.61% |
| 2023 Q2 | -58.27 Million TWD | 69.79% |
| 2022 Q4 | -192.87 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 116.344% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 104.767% |
| Level Biotechnology Inc. | -453.9 Million TWD | 102.774% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 110.444% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 106.412% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 97.481% |
| GlycoNex Incorporation | -148.56 Million TWD | 108.476% |
| VBI | -25.31 Million TWD | 149.739% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 68.728% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 90.875% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 104.795% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 58.82% |
| Visgeneer Inc. | 31.28 Million TWD | 59.749% |
| Mycenax Biotech Inc. | 207 Million TWD | 93.917% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 101.85% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 109.379% |
| Neith Corporation | -150.31 Million TWD | 108.377% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 97.974% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 121.839% |
| Enimmune corporation | -314.15 Million TWD | 104.008% |
| TaiRx, Inc. | -147.86 Million TWD | 108.516% |
| CHO Pharma, Inc. | -203.79 Million TWD | 106.179% |
| EirGenix Inc. | -4.58 Billion TWD | 100.274% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 114.856% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 89.582% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 100.391% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 103.967% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 163.554% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 60.414% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 75.191% |
| RBC Bioscience Corporation | 422.18 Million TWD | 97.017% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 101.333% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 112.408% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 107.623% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 96.001% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 119.577% |
| NaviFUS Corp. | -123.12 Million TWD | 110.227% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 82.996% |
| Sinew Pharma Inc. | -160.34 Million TWD | 107.853% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 105.206% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 103.732% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 103.052% |
| AP Biosciences Inc | -196.52 Million TWD | 106.407% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 98.172% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 210.099% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 101.518% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 99.072% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 103.035% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 106.015% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 108.753% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 103.81% |
| TCI GENE Inc. | -689.25 Million TWD | 101.827% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 110.587% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 100.962% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 38.525% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 112.361% |
| PharmaEngine, Inc. | -860.8 Million TWD | 101.463% |
| Savior Lifetec Corporation | -812.54 Million TWD | 101.55% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 104.198% |
| OBI Pharma, Inc. | -398.22 Million TWD | 103.162% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 103.446% |
| Acepodia, Inc. | -6.02 Billion TWD | 100.209% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 100.37% |